Alercell Spearheads Development of Leukemia Diagnostic Test
Alercell’s leukemia test will use terminal erythroid differentiation for prognostic classification in patients with myeloid malignancies.
Read MorePosted by Andy Lundin | Oct 25, 2023 | Leukemia |
Alercell’s leukemia test will use terminal erythroid differentiation for prognostic classification in patients with myeloid malignancies.
Read MorePosted by Andy Lundin | Oct 24, 2023 | Cancer |
Researchers detected cancer earlier in individuals with Li-Fraumeni syndrome, an inherited condition with a high risk of developing cancer.
Read MorePosted by Andy Lundin | Oct 23, 2023 | Cancer, Molecular Diagnostics |
VolitionRx detailed a new liquid biopsy cancer-detection method at the annual congress of the European Society for Medical Oncology.
Read MorePosted by Andy Lundin | Sep 27, 2023 | Immunoassay |
Mission Bio’s Tapestri Single-cell MRD AML Multiomics Assay is designed to bring resolution to disease relapse in acute myeloid leukemia.
Read MorePosted by Andy Lundin | Sep 13, 2023 | Unknown Origin & Other Cancer Types |
The study’s impact is multifaceted, potentially influencing the development of non-invasive diagnostic tests and novel medicines.
Read More